TIVZ SD (Fotivda 1.34 mg)
Generic Name: tivozanib
Pill with imprint TIVZ SD is Yellow, Capsule-shape and has been identified as Fotivda 1.34 mg. It is supplied by AVEO Oncology.
Fotivda is used in the treatment of renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. Fotivda 1.34 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TIVZ SD
Fotivda
- Generic Name
- tivozanib
- Imprint
- TIVZ SD
- Strength
- 1.34 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- VEGF/VEGFR inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AVEO Oncology
- National Drug Code (NDC)
- 45629-0134
More about Fotivda (tivozanib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Pricing & coupons
- En español
- Drug class: VEGF/VEGFR inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.